Benefits
Weight and waist support
Pooling all five randomized trials, a 2020 systematic review found lower body weight and waist circumference with African mango seed extract. But four of those five trials were rated high risk of bias, and the one trial rated low risk of bias found no significant difference in body weight, waist circumference or fat mass. The positive pooled result therefore rests on the weaker studies.
Appetite and fullness
None of the trials behind this page measured appetite, fullness or food intake, so this is not something the evidence supports. The doses studied are also far below the several grams of fiber used in satiety research.
Metabolic markers
Pooled across the trials, total cholesterol and LDL were lower with African mango, but the trials disagreed with each other so strongly that the pooled figures are hard to interpret. In the one low risk of bias trial, in adults with metabolic syndrome, cholesterol did not change significantly, and the HDL and triglyceride results were trends whose confidence intervals crossed zero.
Mechanism of action
Fat metabolism rather than fiber
Whole dika nut is fiber rich, and early work assumed fiber explained the effects. The concentrated extract sold today is standardized to plant albumin and ellagic acid, and researchers now propose effects on fat breakdown and fat synthesis instead. Neither mechanism has been confirmed in people.
Adipokine signaling
One trial reported large changes in leptin and adiponectin. That trial was part funded by the company that supplied the extract, and it was rated high risk of bias. The review cited on this page does not analyze these hormones, and no low risk of bias trial has measured them.
Clinical trials
Systematic review and meta-analysis of Irvingia gabonensis seed extract on anthropometric and cardiovascular outcomes. (Lee et al. 2020, Journal of the American College of Nutrition)
Five randomized trials: four in Cameroon in adults with overweight or obesity, and one in Mexico in adults with metabolic syndrome. Three of the five came from the same laboratory. The review's authors note the participants were mainly of African ethnicity, which limits how far the findings carry.
Pooled across the five trials, body weight fell by about 9 percent and waist circumference by about 8 percent relative to placebo, with benefits also reported for cholesterol. The caveat matters more than the headline: four of the five trials were rated high risk of bias, and the only trial rated low risk of bias found no significant difference in weight, waist, fat mass or cholesterol. One of the five tested African mango combined with Cissus quadrangularis, so its result cannot be credited to African mango alone. The authors concluded that efficacy seems positive but is limited by poor methodological quality and insufficient reporting, and that further high quality trials are needed.